First, we observed that RBM38 protein expression was commonly decreased in liver cancer cells and HCC compared to normal liver cells and corresponding adjacent liver tissues, while simultaneously associated with increased mdm2 and decreased wtp53. Here, RBM38 is linked to hepatocellular carcinoma.